Comparing an immediate cessation versus reduction approach to smokeless tobacco cessation

Nicotine and Tobacco Research

Volumn 14, Issue 8, 2012, Pages 902-909

  Schiller, Katherine R ^a   Luo, Xianghua ^a   Anderson, Amanda J ^a   Jensen, Joni A ^a   Allen, Sharon S ^b   Hatsukami, Dorothy K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FOLLOW UP; HUMAN; LOZENGE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SELF REPORT; SMOKELESS TOBACCO; SMOKING CESSATION; TELECONSULTATION; TOBACCO DEPENDENCE; TREATMENT DURATION; TREATMENT PLANNING; URINALYSIS;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOTIVATION; NICOTINE; TOBACCO USE CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TOBACCO, SMOKELESS; TREATMENT OUTCOME;

EID: 84865063537     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntr302     Document Type: Article

References (56)

1. Bile, K. M. L. O., Shaikh, J. A., Afridi, H. U., & Khan, Y. (2010). Smokeless tobacco use in Pakistan and its association with oropharyngeal cancer. Eastern Mediterranean Health Journal, 16(Suppl.), S24-S30.
2. Boffetta, P., Hecht, S., Gray, N., Gupta, P., & Straif, K. (2008). Smokeless tobacco and cancer. Lancet Oncology, 9, 667-675. doi:10.1016/S1470-2045(08)70173-6.
3. Bolinder, G., Alfredsson, L., Englund, A., & de Faire, U. (1994). Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. American Journal of Public Health, 84, 399-404. doi:10.2105/AJPH.84.3.399.
4. Boyle, R. G., Enstad, C., Asche, S. E., Thoele, M. J., Sherwood, N. E., Severson, H. H., et al. (2008). A randomized controlled trial of Telephone Counseling with smokeless tobacco users: The ChewFree Minnesota study. Nicotine & Tobacco Research, 10, 1433-1440. doi:10.1080/14622200802279872.
5. Boyle, R. G., Pronk, N. P., & Enstad, C. J. (2004). A randomized trial of telephone counseling with adult moist snuff users. American Journal of Health Behavior, 28, 347-351.
6. Carpenter, M., Hughes, J., & Keely, J. (2003). Effect of smoking reduction on later cessation: A pilot experimental study. Nicotine & Tobacco Research, 5, 155-162. doi:10.1080/146222003100007385.
7. Carpenter, M., Hughes, J. R., Solomon, L. J., & Callas, P. W. (2004). Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. Journal of Consulting and Clinical Psychology, 72, 371-381. doi:10.1037/0022-006X.72.3.371.
8. Centers for Disease Control and Prevention. (1999). Determination of nicotine, pH, and moisture content of six U.S. commercial moist snuff products-Florida, January-February, 1999. Morbidity and Mortality Weekly Report, 48, 398-01.
9. Centers for Disease Control and Prevention. (2010). State-specific prevalence of cigarette smoking and smokeless tobacco use among adults-United States, 2009. Morbidity & Mortality Weekly Report, 59, 1400-1406. doi:mm5943a2[pii].
10. Cigrang, J. A., Severson, H. H., & Peterson, A. L. (2002). Pilot evaluation of a population-based health intervention for reducing use of smokeless tobacco. Nicotine & Tobacco Research, 4, 127-131. doi:10.1080/14622200110101603.
11. Dale, L. C., Ebbert, J. O., Glover, E. D., Croghan, I. T., Schroeder, D. R., Severson, H. H., et al. (2007). Bupropion SR for the treatment of smokeless tobacco use. Drug and Alcohol Dependence, 90, 56-63. doi:10.1016/j.drugalcdep.2007.02.008.
12. Dale, L. C., Ebbert, J. O., Schroeder, D. R., Croghan, I. T., Rasmussen, D. F., Trautman, J. A., et al. (2002). Bupropion for the treatment of nicotine dependence in spit tobacco users: A pilot study. Nicotine & Tobacco Research, 4, 267-274. doi:10.1080/14622200210153821.
13. Ebbert, J. O., Croghan, I. T., Severson, H. H., Schroeder, D. R., & Hays, J. T. (2011). A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States. Nicotine & Tobacco Research, 13, 820-826. doi:10.1093/ntr/ntr078.
14. Ebbert, J. O., Dale, L. C., Patten, C. A., Croghan, I. T., Schroeder, D. R., Moyer, T. P., et al. (2007). Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users. Nicotine & Tobacco Research, 9, 43-52. doi:10.1080/14622200601078285.
15. Ebbert, J. O., Edmonds, A., Luo, X., Jensen, J., & Hatsukami, D. K. (2010). Smokeless tobacco reduction with the nicotine lozenge and behavioral intervention. Nicotine & Tobacco Research, 12, 823-827. doi:10.1093/ntr/ntq088.
16. Ebbert, J. O., Severson, H. H., Croghan, I. T., Danaher, B. G., & Schroeder, D. R. (2009). A randomized clinical trial of nicotine lozenge for smokeless tobacco use. Nicotine & Tobacco Research, 11, 1415-1423. doi:10.1093/ntr/ntp154.
17. Etter, J., Laszlo, E., & Perneger, T. V. (2004). Postintervention effect of nicotine replacement therapy on smoking reduction in smokers who are unwilling to quit: Randomized trial. Journal of Clinical Psychophamacology, 24, 1-6. doi:10.1097/01.jcp.0000115666.45074.d6.
18. Etter, J., Perneger, T. V., & Ronchi, A. (1997). Distributions of smokers by stage: International comparison and association with smoking prevalence. Preventive Medicine, 26, 580-585. doi:10.1006/pmed.1997.0179.
19. Fagerström, K., Gilljam, H., Metcalfe, M., Tonstad, S., & Messig, M. (2010). Stopping smokeless tobacco with varenicline: Randomised double blind placebo controlled trial. British Medical Journal, 341, c6549. doi:10.1136/bmj.c6549.
20. Falba, T., Jofre-Bonet, M., Busch, S., Duchovny, N., & Sindelar, J. (2004). Reduction of quantity smoked predicts future cessation among older smokers. Addiction, 99, 93-102. doi:10.1111/j.1360-0443.2004.00574.x.
21. Farkas, A. J. (1999). When does cigarette fading increase the likelihood of future cessation? Annals of Behavioral Medicine, 21, 71-76. doi:10.1007/BF02895036.
22. Fiore, M., Bailey, W., Cohen, S., Dorfman, S., Goldstein, M., Gritz, E., et al. (2000). Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service.
23. Fu, M., Fernandez, E., Pascual, J. A., Martinez-Sanchez, J. M., Agudo, A., Moncada, A., et al. (2011). Stages of change, smoking characteristics, and cotinine concentrations in smokers: Setting priorities for smoking cessation. Preventive Medicine, 52, 139-145. doi:10.1016/j.ypmed.2010.12.003.
24. Hatsukami, D., Ebbert, J. O., Anderson, A., Lin, H., Le, C., & Hecht, S. S. (2007). Smokeless tobacco brand switching: A means to reduce toxicant exposure? Drug and Alcohol Dependence, 87, 217-224. doi:10.1016/j.drugalcdep.2006.08.021.
25. Hatsukami, D., Ebbert, J. O., Edmonds, A., Li, C., Lin, H., Le, C., et al. (2008). Smokeless tobacco reduction: Preliminary study of tobacco-free snuff versus no snuff. Nicotine & Tobacco Research, 10, 77-85. doi:10.1080/14622200701704897.
26. Hatsukami, D., Grillo, M., Boyle, R., Allen, S., Jensen, J., Bliss, R., et al. (2000). Treatment of spit tobacco users with transdermal nicotine system and mint snuff. Journal of Consulting and Clinical Psychology, 68, 241-249. doi:10.1037/0022-006X.68.2.241.
27. Hatsukami, D., Jensen, J., Allen, S., Grillo, M., & Bliss, R. (1996). The effects of behavioral and pharmacological treatment on smokeless tobacco users. Journal of Consulting and Clinical Psychology, 64, 153-161.
28. Hatsukami, D., &Severson, H. (1999). Oral spit tobacco: Addiction, prevention and treatment. Nicotine & Tobacco Research, 1,21-44.
29. Hecht, S. S., Carmella, S. G., Chen, M., Dor Koch, J. F., Miller, A. T., et al. (1999). Quantitation of urinary metabolites of atobacco-specific lung carcinogen after smoking cessation. Cancer Research, 59, 590-596.
30. Henley, S. J., Thun, M. J., Connell, C., &Calle, E. E. (2005). Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes & Control, 16, 347-358. doi:10.1007/s10552-004-5519-6.
31. Howard-Pitney, B., Killen, J. D., & Fortmann, S. P. (1999). Quitting chew: Results from a randomized trial using nicotine patches. Experimental and Clinical Psychopharmacology, 7, 362-371. doi:10.1037/1064-1297.7.4.362.
32. Hughes, J., Lindgren, P., Connett, J., &Nides, M. (2004). Smoking reduction in the lung health study. Nicotine & Tobacco Research, 6, 275-280. doi:10.1080/14622200410001676297.
33. Hyland, A., Levy, D. T., Rezaishiraz, H., Hughes, J. R., Bauer, J. E., Giovino, G. A., et al. (2005). Reduction in amount smoked predicts future cessation. Psychology of Addictive Behaviors, 19, 221-225. doi:10.1037/0893-164X.19.2.221.
34. International Agency for Research on Cancer. (2007). Smokeless tobacco and some tobacco-specific nitrosamines (Vol. 89). Lyon, France: Author.
35. Jacob, P., III, Hatsukami, D., Severson, H., Hall, S., Yu, L., & Benowitz, N. L. (2002). Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy. Cancer Epidemiology, Biomarkers & Prevention, 11,1668-1673.
36. Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2011). Monitoring the future national results on adolescent drug use: Overview of key findings, 2010. Ann Arbor, MI: Institute for Social Research, The University of Michigan.
37. Joseph, A. M., Hecht, S. S., Murphy, S. E., Lando, H., Carmella, S. G., Gross, M., et al. (2008). Smoking reduction fails to improve clinical and biological markers of cardiac disease: A randomized controlled trial. Nicotine & Tobacco Research, 10, 471-481. doi:10.1080/14622200801901948.
38. Murphy, S. E., Link, C. A., Jensen, J., Le, C., Puumala, S. S., Hecht, S. S., et al. (2004). A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers. Cancer Epidemiology, Biomarkers and Prevention, 13, 1617-1623.
39. Norberg, M., Stenlund, H., Lindahl, B., Boman, K., & Weinehall, L. (2006). Contribution of Swedish moist snuff to the metabolic syndrome: A wolf in sheep's clothing? Scandinavian Journal of Public Health, 34, 576-583. doi:10.1080/14034940600665143.
40. Persson, P. G., Carlsson, S., Svanstrom, L., Ostenson, C. G., Efendic, S., & Grill, V. (2000). Cigarette smoking, oral moist snuff use and glucose intolerance. Journal of Internal Medicine, 248, 103-110. doi:10.1046/j.1365-2796.2000.00708.
41. Piano, M. R., Benowitz, N. L., Fitzgerald, G. A., Corbridge, S., Heath, J., Hahn, E., et al. (2010). Impact of smokeless tobacco products on cardiovascular disease: Implications for policy, prevention, and treatment: A policy statement from the American Heart Association. Circulation, 122, 1520-1544. doi:10.1161/CIR.0b013e3181f432c3.
42. Rennard, S. I., Glover, E. D., Leischow, S., Daughton, D. M., Glover, P. N., Muramoto, M., et al. (2006). Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial. Nicotine & Tobacco Research, 8, 555-564. doi:10.1080/14622200600789916.
43. Richter, P., Hodge, K., Stanfill, S., Zhang, L., & Watson, C. (2008). Surveillance of moist snuff total nicotine, pH, moisture, un-ionized nicotine, and tobacco-specific nitrosamine content. Nicotine & Tobacco Research, 10,1645-1652. doi:10.1080/14622200802412937.
44. Rogers, J. M. (2009). Tobacco and pregnancy. Reproductive Toxicology, 28, 152-160. doi:10.1016/j.reprotox.2009.03.012.
45. Severson, H. H., Andrews, J., Lichtenstein, E., Gordon, J., & Barckley, M. (1998). Using the hygiene visit to deliver a tobacco cessation program: Results of a randomized clinical trial. Journal of the American Dental Association, 129, 993-999.
46. Severson, H. H., Gordon, J. S., Danaher, B. G., & Akers, L. (2008). ChewFree.com: Evaluation of a Web-based cessation program for smokeless tobacco users. Nicotine & Tobacco Research, 10, 381-391. doi:10.1080/14622200701824984.
47. Severson, H. H., Peterson, A. L., Andrews, J. A., Gordon, J. S., Cigrang, J. A., Danaher, B. G., et al. (2009). Smokeless tobacco cessation in military personnel: A randomized controlled trial. Nicotine & Tobacco Research, 11,730-738. doi:10.1093/ntr/ntp057.
48. Society for Research on Nicotine and Tobacco Subcommittee on Biochemical Verification. (2002). Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research, 4, 149-159. doi:10.1080/14622200210123581.
49. Stotts, R. C., Roberson, P. K., Hanna, E. Y., Jones, S. K., & Smith, C. K. (2003). A randomised clinical trial of nicotine patches for treatment of spit tobacco addiction among adolescents. Tobacco Control, 12(Suppl. 4), IV11-IV15. doi:10.1136/tc.12.suppl_4.iv11.
50. Teo, K. K., Ounpuu, S., Hawken, S., Pandey, M. R., Valentin, V., Hunt, D., et al. (2006). Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: A case-control study. Lancet, 368, 647-658. doi:10.1016/S0140-736(06)69249-0.
51. U.S. Department of Health and Human Services. (1986). The health consequences of using smokeless tobacco: A report of the advisory committee to the Surgeon General. Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service.
52. Wallstrom, M., Bolinder, G., Hasseus, B., & Hirsch, J. M. (2010). A cessation program for snuff-dippers with long-term, extensive exposure to Swedish moist snuff: A 1-year follow-up study. Acta Odontol Scand, 68, 377-384. doi:10.3109/00016357.2010.514734.
53. Walsh, M. M., Hilton, J. F., Ellison, J. A., Gee, L., Chesney, M. A., Tomar, S. L., et al. (2003). Spit (Smokeless) Tobacco Intervention for High School Athletes: Results after 1 year. Addictive Behavior, 28,1095-1113. doi:S0306460302002289[pii].
54. Weitkunat, R., Sanders, E., & Lee, P. N. (2007). Meta-analysis of the relation between European and American smokeless tobacco and oral cancer. BMC Public Health, 7, 334. doi:10.1186/1471-2458-7-334.
55. Wennike, P., Danielsson, T., Landfeldt, B., Westin, A., & Tonnesen, P. (2003). Smoking reduction promotes smoking cessation: Results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction, 98, 1395-1402. doi:10.1046/j.1360-0443.2003.00489.x.
56. Wewers, M. E., Stillman, F. A., Hartman, A. M., & Shopland, D. R. (2003). Distribution of daily smokers by stage of change: Current population survey results. Preventive Medicine, 36, 710-720. doi:10.1016/S0091-7435(03)00044-6.